Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

321
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
321
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

240
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
240
Genetic Lingo01:11

Genetic Lingo

100.8K
Overview
100.8K
Incomplete Dominance01:43

Incomplete Dominance

21.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
21.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and EEG features integrated by a deep learning method to investigate treatment outcomes in epilepsy with eyelid myoclonia.

Seizure·2026
Same author

Health-Related Quality of Life and Family Impact Among Children with Epilepsy: The Role of Seizure Control.

Neuroepidemiology·2026
Same author

PARS2 deficiency impairs mitochondrial homeostasis and activates ferroptotic to drive developmental and epileptic encephalopathy.

Free radical biology & medicine·2026
Same author

Phenotype and genotype of AKT3-related disorders.

Seizure·2026
Same author

KCNA2 Variants in Epilepsy: Focusing on Spike-and-Wave Activation in Sleep.

Pediatric neurology·2026
Same author

Cross-sectional study on the relationship between sarcopenia indicators and lung function in a community-dwelling population.

Frontiers in nutrition·2026

Related Experiment Video

Updated: Jun 3, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

SETD1B variants associated with absence seizures.

Genfu Zhang1, Yue Niu1, Zhao Xu1

  • 1Department of Pediatrics, Peking University People's Hospital, Beijing, China; Epilepsy Center, Peking University People's Hospital, Beijing, China.

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|January 7, 2025
PubMed
Summary
This summary is machine-generated.

Genetic variants in SETD1B are associated with absence seizures (ASs) in pediatric patients. These SETD1B alterations may impact neuronal function and contribute to the development of AS, influencing brain development and cognitive function.

Keywords:
Absence seizuresEpilepsyGeneSETD1B

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.5K
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.5K
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.8K

Area of Science:

  • Genetics
  • Neuroscience
  • Epilepsy Research

Background:

  • Absence seizures (ASs) are a type of epilepsy with complex genetic underpinnings.
  • SETD1B gene variants have been implicated in neurodevelopmental disorders, but their specific role in AS remains under investigation.

Purpose of the Study:

  • To explore the association between variants in the SETD1B gene and the occurrence of absence seizures (ASs).
  • To investigate the clinical phenotype and genetic landscape of individuals with SETD1B variants and ASs.

Main Methods:

  • A cohort of four pediatric epilepsy patients with identified SETD1B variants was studied.
  • Trio-based whole-exome sequencing was used for genetic screening.
  • A literature review of 50 documented cases of ASs linked to SETD1B alterations was conducted.

Main Results:

  • Four new cases presented with developmental impediments, cognitive deficits, and epileptic manifestations.
  • Of 54 individuals, 48.1% had ASs, with a median onset age of 44.8 months.
  • SETD1B variants in SET domains were found in 46.2% of AS patients, often with cognitive and autistic traits.

Conclusions:

  • SETD1B variants are potentially influential in the pathogenesis of ASs, possibly by affecting neuronal excitability through histone methylation.
  • The study highlights the significance of ASs within the SETD1B phenotype and suggests SET domains' role in AS pathogenesis.